Winton Group LTD Iovance Biotherapeutics, Inc. Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$5.53 - $8.22 $1,150 - $1,709	208 Added 1.11%	18,929 $115,000
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $4,939 - $8,790	879 Added 4.93%	18,721 $119,000
Q3 2022 Nov 10, 2022	BUY	$9.53 - $13.11 $170,034 - $233,908	17,842 New	17,842 $171,000
Q2 2022 Aug 10, 2022	SELL	$6.38 - $18.33 $103,292 - $296,762	-16,190 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$12.38 - $19.1 $38,241 - $58,999	3,089 Added 23.58%	16,190 $270,000
Q4 2021 Feb 10, 2022	BUY	$16.55 - $27.63 $216,821 - $361,980	13,101 New	13,101 $250,000
Q1 2021 Jul 21, 2021	SELL	$28.67 - $52.59 $437,618 - $802,733	-15,264 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$28.04 - $50.26 $86,952 - $155,856	-3,101 Reduced 16.89%	15,264 $708,000
Q3 2020 Oct 30, 2020	BUY	$27.75 - $36.3 $509,628 - $666,649	18,365 New	18,365 $605,000

320

238M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.